ArticleNature communications2024
Rapid expansion and international spread of M1
Abstract read
In one paragraph
Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.
0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
72 citing papers in PubMed.
- Tracing the recent evolution of Group AEmerging microbes & infections · 2026Review
- Predominance of M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Genomic analysis and clinical characteristics of a seasonal upsurge of Streptococcus pyogenes emm12.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.Current opinion in infectious diseases · 2026Review
- Genomic analysis of Streptococcus pyogenes emm1-type isolates reveals M1European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Molecular characterization of covRS mutations in M1FEBS open bio · 2026Article
- Whole Genome Sequencing Analysis of Group AJournal of Korean medical science · 2026Article
- M1UK LineageInfection & chemotherapy · 2026Article
- Epidemiology and clinical characteristics of invasive group A streptococcal infection in the Republic of Korea, 2015-2024: a nationwide multicenter study.The Lancet regional health. Western Pacific · 2026Article
- The role of school terms in the epidemics of scarlet fever among pre-school-aged and school-aged children: a 15-year population-based surveillance in China.BMC public health · 2026Article
- Unravelling the unique essential genes ofMicrobial genomics · 2026Article
- Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in China.Nature microbiology · 2026Article
- Carbon metabolism and niche adaptation inmSphere · 2026Review
- Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.NPJ vaccines · 2026Review
- Increased burden of invasive group A streptococcal disease among Australian children, 2023-2024: a prospective cohort study.The Lancet regional health. Western Pacific · 2026Article
- Fatal Streptococcus pyogenes infections in Spain, Turkey, UK and Belgium after pandemics: a comprehensive case series combining microbiology with autopsy findings. A study of the ESCMID study group for forensic and post-mortem microbiology (ESGFOR).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Primary care pharyngotonsillitis complications following absent or deferred antibiotic treatment across the COVID 19 pandemic.Communications medicine · 2026Article
- Article
- Before and after the bottleneck: pediatric group A streptococcal infections in Houston, TX, from 2013 to 2023.Microbiology spectrum · 2026Article
- Acquisition of toxin-encoding lysogenic bacteriophage elements enhances the virulence of pandemicInfection and immunity · 2026Article
12 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Ana VieiraDepartment of Infectious Disease, Imperial College London, London, UK.
Yu WanDepartment of Infectious Disease, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8354-7647
Yan RyanReference Services Division, UK Health Security Agency, London, UK.
Ho Kwong LiDepartment of Infectious Disease, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-8149-5943
Rebecca L GuyHealthcare-Associated Infections, Fungal, AMR, AMU, and Sepsis Division, UK Health Security Agency, London, UK.
Maria PapangeliDepartment of Infectious Disease, Imperial College London, London, UK.
Kristin K HuseDepartment of Infectious Disease, Imperial College London, London, UK.
Lucy C ReevesDepartment of Infectious Disease, Imperial College London, London, UK.
Valerie W C SooDepartment of Infectious Disease, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-0214-5070
Roger DanielReference Services Division, UK Health Security Agency, London, UK.
Alessandra HarleyReference Services Division, UK Health Security Agency, London, UK.
Karen BroughtonReference Services Division, UK Health Security Agency, London, UK.
Chenchal DhamiReference Services Division, UK Health Security Agency, London, UK.
Mark GannerReference Services Division, UK Health Security Agency, London, UK.
Marjorie A GannerReference Services Division, UK Health Security Agency, London, UK.
Zaynab MuminReference Services Division, UK Health Security Agency, London, UK.
Maryam RazaeiReference Services Division, UK Health Security Agency, London, UK.
Emma RundbergReference Services Division, UK Health Security Agency, London, UK.
Rufat MammadovReference Services Division, UK Health Security Agency, London, UK.
Ewurabena A MillsDepartment of Infectious Disease, Imperial College London, London, UK.
Vincenzo SgroDepartment of Infectious Disease, Imperial College London, London, UK.
Kai Yi MokDepartment of Infectious Disease, Imperial College London, London, UK.
Xavier DidelotSchool of Life Sciences and Department of Statistics, University of Warwick, Coventry, UK.ORCID http://orcid.org/0000-0003-1885-500X
Nicholas J CroucherSchool of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-6303-8768
Elita JauneikaiteNIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-7075-6896
Theresa LamagniNIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.
Colin S BrownNIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-4776-3403
Juliana CoelhoNIHR Health Protection Research Unit in Healthcare-associated Infections and AMR, Imperial College London, London, UK. Juliana.coelho@ukhsa.gov.uk.ORCID http://orcid.org/0000-0002-8972-7673
Shiranee SriskandanDepartment of Infectious Disease, Imperial College London, London, UK. s.sriskandan@imperial.ac.uk.ORCID http://orcid.org/0000-0002-5214-4941
Funding
Medical Research Council MR/R015600/1Medical Research Council MR/T016434/1RCUK | Medical Research Council (MRC) MR/P022669/1RCUK | Medical Research Council (MRC) MR/X001962/1
Abstract
The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1
Indexed as
COVID-19PhylogenyStreptococcal InfectionsStreptococcus pyogenesBacterial ProteinsEuropeGenome, BacterialHumansMutationPandemicsRepressor ProteinsSARS-CoV-2Scarlet FeverUnited KingdomBacterial ProteinsCsrR protein, Streptococcus pyogenesRepressor Proteins
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.